Bacterial infection with a resistant staphylococcal species in dogs (Methicillin-resistant Staphylococcus aureus infections, MRSA)

  • Synonyms: Multiresistant Staphylococcus aureus, Oxacillin-resistant Staphylococcus aureus (ORSA)
  • Occurrence: rarer
  • Location of disease: General/Whole body
Author: Dr. med. vet. Gisa Löwe | Last modified: 22.08.2026
Open table of contents

When to visit the vet?

Non-urgent see a veterinarian within 2–3 days

?

If the condition worsens / symptoms persist, consult a veterinarian.

Download/Print

Definition

Methicillin-resistant Staphylococcus aureus infections (MRSA) in dogs are bacterial infections caused by a resistant form of Staphylococcus aureus. These infections are difficult to treat because they are resistant to many common antibiotics.

The most important facts at a glance

MRSA, or methicillin-resistant Staphylococcus aureus, is a special form of bacteria that is resistant to many antibiotics. These bacteria can lead to infections in dogs, especially when the immune system is weakened or tissue damage is present. Reasons for the resistance are genetic mutations and the uncritical use of antibiotics, which has contributed to the spread of resistant strains. Dogs can pick up MRSA through close contact with infected humans or contaminated environments. Risk factors are frequent hospitalizations, surgeries, and chronic skin diseases. Symptoms include fever, skin inflammation, and purulent wounds. The diagnosis is made by detecting the bacteria in tissue samples and determining antibiotic sensitivity. Treatment is difficult because many antibiotics are ineffective; targeted therapy based on sensitivity testing is crucial. Prevention includes good hygiene and responsible antibiotic use. Research focuses on transmission routes, faster diagnostic procedures, and new treatment methods. The prognosis varies depending on infection severity and the dog’s health status, but early diagnosis and targeted treatment improve recovery chances. Continuous monitoring is important to avoid relapses.

Causes

Staphylococcus aureus is a common bacterium that lives on the skin and mucous membranes of many animals and humans. Normally it does not cause problems, but it can lead to infections if the immune system is weakened or if there is tissue damage. MRSA is a special form of this bacterium that is resistant to methicillin and other antibiotics.

The resistance of MRSA to antibiotics is the result of genetic mutations and the selective survival of these resistant strains during repeated antibiotic treatment. In veterinary medicine, the use of antibiotics was often uncritical in the past, which contributed to the emergence and spread of resistant bacterial strains. Close contact between MRSA carriers and their pets can also promote transmission to animals.

Other risk factors for the development of MRSA infections in dogs include frequent hospitalizations, surgical procedures, and the presence of chronic skin diseases. Since MRSA can survive in the environment, dogs can also pick up the bacteria in contaminated surroundings.

Symptoms

Rare symptoms:

The symptoms of an MRSA infection in dogs can vary depending on the affected body region. Skin infections are common, manifesting through redness, swelling, pain, and pus formation. Abscesses and non-healing wounds are also frequent signs.

If the bacteria enters the bloodstream, it can lead to systemic infections that cause fever, loss of appetite, weakness, and lethargy. In severe cases, an MRSA infection can lead to life-threatening sepsis.

Infections of the respiratory tract, urinary tract, or joints are other possible manifestations. These can bring specific symptoms such as cough, shortness of breath, increased thirst and urination, or lameness.

Therapy

Treating MRSA infections in dogs is a challenge because many common antibiotics are ineffective. Targeted antibiotic therapy, based on the results of sensitivity testing, is crucial. Often, less frequently used or more expensive antibiotics must be used.

Topical treatments and wound care may also be necessary, especially for skin infections. Regular cleaning and disinfecting of the affected areas support the healing process.

In severe cases, inpatient treatment may be necessary to allow for intensive care and intravenous medication. Supportive measures such as fluid therapy and pain management can also be part of the treatment.

Prognosis and follow-up care

The prognosis for dogs with MRSA infections varies depending on the severity and spread of the infection as well as the animal’s general health. Early diagnosis and targeted treatment significantly improve the chances of recovery.

Dogs that respond to treatment can fully recover, although recovery may take longer in severe infections. In cases where the infection is advanced or the dog’s immune system is severely weakened, the prognosis may be less favorable.

A relapse of the infection is possible, especially if not all bacteria were eliminated or if the animal is exposed again. Continuous monitoring and follow-up care are therefore important.

Prevention

Preventive measures are crucial to reduce the risk of MRSA infections in dogs. Good hygiene, including regular cleaning and disinfecting of the environments where the dog spends time, can help prevent the spread of bacteria.

Responsible use of antibiotics is also important to avoid the development of resistant bacteria. Antibiotics should only be used on veterinary instruction, and the complete treatment should be completed even when symptoms have already subsided.

Dogs at increased risk for MRSA infections, such as those frequently in veterinary hospitals, benefit from regular health examinations. If MRSA is suspected, veterinary advice should be sought immediately to prevent the spread of the infection.

Outlook on current research

Research on methicillin-resistant Staphylococcus aureus infections (MRSA) in dogs has increased significantly in recent years, as the importance of these infections for public health and veterinary care becomes increasingly clear. One of the main focuses of current research is the investigation of transmission routes of MRSA between humans and animals. Since MRSA is a known zoonosis, i.e., a disease that can be transmitted between animals and humans, understanding these transmission routes is required to develop effective prevention and control strategies.

Another important research area is the development and improvement of diagnostic tests that enable faster and more accurate identification of MRSA infections in dogs. Traditionally, the diagnosis of MRSA cultures takes several days, which delays treatment. New molecular techniques based on polymerase chain reaction (PCR) enable faster identification of bacteria and help control the spread of the infection.

The resistance mechanisms of MRSA are also a central research point. Scientists are investigating the genetic factors that lead to antibiotic resistance and are trying to develop new therapeutic approaches to overcome them. Work is also being done on the development of new antibiotics that are effective against MRSA infections, as well as alternative treatments such as phage therapy and immunomodulatory strategies.

In addition to medical research, it is being investigated how environmental factors contribute to the spread of MRSA. Studies on the role of animal shelters, veterinary hospitals, and other environments where dogs are in close contact with each other provide important insights into how the spread of MRSA in such environments can be controlled. These insights are crucial for the development of infection control guidelines.

Finally, research is also examining preventive measures to minimize the risk of MRSA infections in dogs. These include programs for better education of pet owners and veterinarians about the importance of hygiene practices, regular monitoring of MRSA in animal populations, and research into vaccines that could possibly be used in the future for the prevention of infections. All these research efforts contribute to minimizing the impact of MRSA on both animal health and public health.

Frequently Asked Questions (FAQs)

1. What is MRSA in dogs?
MRSA in dogs is an infection with Staphylococcus aureus bacteria that are resistant to methicillin and other antibiotics. These infections can cause skin infections, wound infections, or even systemic diseases.
2. How do you recognize an MRSA infection in dogs?
Symptoms of an MRSA infection in dogs often include skin irritation, redness, swelling, pus formation, and sometimes fever. However, an accurate diagnosis requires laboratory tests to identify the bacteria.
3. How is MRSA treated in dogs?
Treating MRSA in dogs can be difficult because the bacteria are resistant to many antibiotics. Veterinarians often use a combination of antibiotics that are still effective and supportive care to fight the infection.
4. Can MRSA be transmitted from dogs to humans?
Yes, MRSA is a zoonosis, which means it can be transmitted between animals and humans. Close contact with an infected pet can increase the risk of transmission.
5. How can you reduce the risk of an MRSA infection in dogs?
Good hygiene practices, such as regular hand washing after contact with dogs and the care of wounds, can reduce the risk of an MRSA infection. Regular veterinary check-ups can also help detect infections early.
6. Are certain dog breeds more susceptible to MRSA?
There are no specific dog breeds known to be more susceptible to MRSA. All dogs can potentially become infected, especially if they have open wounds or a weakened immune system.
7. Can MRSA infections in dogs be completely cured?
With the right treatment, many MRSA infections in dogs can be successfully treated, although this may require time and careful monitoring by a veterinarian.
8. How does MRSA spread among dogs?
MRSA can spread through direct contact between dogs or through contaminated objects and surfaces. Animal shelters and veterinary clinics can be particularly susceptible to the spread of MRSA.
9. Are dogs tested for MRSA?
Dogs are usually only tested for MRSA if they show symptoms of an infection typical of MRSA or if they live in an environment where MRSA is known to be present.
10. Are there vaccines against MRSA for dogs?
There are currently no specific vaccines against MRSA for dogs. However, research in this area is active, and in the future, vaccines could be an option for preventing infections.

Literature

  • Morris, D. O., Loeffler, A., Davis, M. F., Guardabassi, L., & Weese, J. S. (2017). Recommendations for approaches to meticillin-resistant staphylococcal infections of small animals: Diagnosis, therapeutic considerations and preventative measures. Clinical Consensus Guidelines of the World Association for Veterinary Dermatology. Veterinary Dermatology, 28(3), 304–e69. https://doi.org/10.1111/vde.12444
  • Loeffler, A., Cain, C. L., Ferrer, L., Nishifuji, K., Varjonen, K., Papich, M. G., Guardabassi, L., Frosini, S. M., Barker, E. N., & Weese, J. S. (2025). Antimicrobial use guidelines for canine pyoderma by the International Society for Companion Animal Infectious Diseases (ISCAID). Veterinary Dermatology, 36(3), 234–282. https://doi.org/10.1111/vde.13342
  • Duquette, R. A., & Nuttall, T. J. (2004). Methicillin-resistant Staphylococcus aureus in dogs and cats: An emerging problem? Journal of Small Animal Practice, 45(12), 591–597. https://doi.org/10.1111/j.1748-5827.2004.tb00202.x
  • Leonard, F. C., & Markey, B. K. (2008). Meticillin-resistant Staphylococcus aureus in animals: A review. Veterinary Journal, 175(1), 27–36. https://doi.org/10.1016/j.tvjl.2006.11.008
  • Weese, J. S., & van Duijkeren, E. (2010). Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius in veterinary medicine. Veterinary Microbiology, 140(3–4), 418–429. https://doi.org/10.1016/j.vetmic.2009.01.039
  • Faires, M. C., Traverse, M., Tater, K. C., Pearl, D. L., & Weese, J. S. (2010). Methicillin-resistant and -susceptible Staphylococcus aureus infections in dogs. Emerging Infectious Diseases, 16(1), 69–75. https://doi.org/10.3201/eid1601.081758
  • van Duijkeren, E., Wolfhagen, M. J. H. M., Box, A. T. A., Heck, M. E. O. C., Wannet, W. J. B., & Fluit, A. C. (2004). Human-to-dog transmission of methicillin-resistant Staphylococcus aureus. Emerging Infectious Diseases, 10(12), 2235–2237. https://doi.org/10.3201/eid1012.040387
  • Feuer, L., Frenzer, S. K., Merle, R., Leistner, R., Bäumer, W., Bethe, A., Lübke-Becker, A., Klein, B., & Bartel, A. (2024). Prevalence of MRSA in canine and feline clinical samples from one-third of veterinary practices in Germany from 2019–2021. Journal of Antimicrobial Chemotherapy, 79(9), 2273–2280. https://doi.org/10.1093/jac/dkae225